Pediatric allergic rhinitis drug therapy.
Hagemann
Tracy M
TM
College of Pharmacy, University of Oklahoma, Oklahoma City, USA. mann@ouhsc.edu
D000367:Age Factors; D000893:Anti-Inflammatory Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002648:Child; D018680:Cholinergic Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D016903:Drug Monitoring; D004781:Environmental Exposure / Q000009:adverse effects / Q000517:prevention & control; D005260:Female; D006634:Histamine H1 Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D020024:Leukotriene Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D008297:Male; D014663:Nasal Decongestants / Q000494:pharmacology / Q000627:therapeutic use*; D018579:Patient Selection; D012221:Rhinitis, Allergic, Perennial / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology; D006255:Rhinitis, Allergic, Seasonal / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology; D012307:Risk Factors; D012720:Severity of Illness Index
D000893:Anti-Inflammatory Agents; D018680:Cholinergic Antagonists; D006634:Histamine H1 Antagonists; D020024:Leukotriene Antagonists; D014663:Nasal Decongestants